Risk of subsequent primary cancers in bladder cancer survivors
Clinical and Experimental Medicine · 2024
DOI: 10.1007/s10238-024-01502-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Yadong Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, People's Republic of China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cancer Survivors, Neoplasms, Second Primary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We aimed to investigate the risk of bladder cancer (BCa) survivors developing or dying from 15 specific-subsequent primary cancers (SPCs). A total of 229,554 BCa survivors were identified from the Surveillance, Epidemiology, and End Results database. Incidence and mortality per 10,000 person-years, absolute excess risk (AER) per 10,000 person-years, standardized incidence ratios, and standardized mortality ratios were calculated. Among BCa survivors, 38,207 developed SPCs and 17,546 died of SPCs. The risk of developing and dying from SPCs was significantly high for 10 and 6 of the 12 common SPCs in men, respectively, while for 6 and 5 of the 14 common SPCs in women, respectively. The SPCs with high risk of development in men were colorectal, breast, liver, and pancreatic cancer, and the ones with high risk of death were liver and pancreatic cancer. Moreover, SPCs with a high risk of development or death among young BCa survivors include ureter, kidney and renal pelvis, and lung cancer. In addition, BCa survivors within 1 year of diagnosis have a significantly higher risk of development and death from ureter, kidney and renal pelvis, prostate, and cervix cancer, but a lower risk of prostate cancer than the general population after 5 years of diagnosis. Lung cancer had a significantly high risk of development but a low risk of death. Among BCa survivors, the risk of developing or dying from few SPCs is significantly high. These findings may provide an important basis for clinical follow-up of BCa survivors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, School of Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, People's Republic of China.
- Urologic Cancer Institute, Tongji University School of Medicine, 301 Yanzhong Road, Jing'an District, Shanghai, 200040, China.
- Department of Medical Statistics, Tongji University School of Medicine, Shanghai, 200092, China. zhangah@tongji.edu.cn.
- Department of Urology, School of Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, People's Republic of China. yaoxudong1967@163.com.
- Urologic Cancer Institute, Tongji University School of Medicine, 301 Yanzhong Road, Jing'an District, Shanghai, 200040, China. yaoxudong1967@163.com.
Zitieren
APA
Guo, Y., Zhang, Y., Mao, S., Zhang, W., Yang, F., Wang, R., Chen, H., Zhang, A., & Yao, X. (2024). Risk of subsequent primary cancers in bladder cancer survivors. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01502-0
Vancouver
Guo Y, Zhang Y, Mao S, Zhang W, Yang F, Wang R, et al. Risk of subsequent primary cancers in bladder cancer survivors. Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01502-0
BibTeX
@article{Guo2024,
author = {Guo, Yadong and Zhang, Yuke and Mao, Shiyu and Zhang, Wentao and Yang, Fuhan and Wang, Ruiliang and Chen, Haotian and Zhang, Aihong and Yao, Xudong},
title = {Risk of subsequent primary cancers in bladder cancer survivors},
journal = {Clinical and Experimental Medicine},
year = {2024},
doi = {10.1007/s10238-024-01502-0}
}
EUVIMED